Penumbra (PEN) Accumulated Depreciation & Amortization (2014 - 2025)
Penumbra (PEN) reported Accumulated Depreciation & Amortization of $17.5 million for Q4 2025, down 26.29% year-over-year from $23.7 million in Q4 2024, and down 26.29% on a QoQ basis from $23.7 million in Q4 2024.
Penumbra (PEN) has 12 years of Accumulated Depreciation & Amortization data on file, last reported at $17.5 million in Q4 2025.
- Quarterly Accumulated Depreciation & Amortization fell 26.29% year-over-year to $17.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $17.5 million (down 26.29% YoY) and the FY2025 annual result came in at $17.5 million, down 26.29% from the prior year.
- Accumulated Depreciation & Amortization slipped to $17.5 million in Q4 2025 per PEN's latest filing, from $23.7 million in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $27.3 million in Q4 2023 and bottomed at $13.3 million in Q2 2023.
- The 5-year median for Accumulated Depreciation & Amortization is $19.3 million (2024), against an average of $19.7 million.
- The widest annual swing landed in 2022, when Accumulated Depreciation & Amortization surged 48.23%; it then slipped 26.29% in 2025.
- Tracing PEN's Accumulated Depreciation & Amortization over 5 years: stood at $16.4 million in 2021, then jumped by 48.23% to $24.3 million in 2022, then rose by 12.07% to $27.3 million in 2023, then declined by 13.04% to $23.7 million in 2024, then fell by 26.29% to $17.5 million in 2025.
- Per Business Quant, the three latest PEN Accumulated Depreciation & Amortization figures stand at $17.5 million (Q4 2025), $23.7 million (Q4 2024), and $19.3 million (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Penumbra | 12.52 Bn | 11.91 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.47 Mn |
| Dec 31, 2025 | 17.47 Mn |
| Dec 31, 2024 | 23.70 Mn |
| Dec 31, 2024 | 23.70 Mn |
| Sep 30, 2024 | 19.31 Mn |
| Sep 30, 2024 | 19.31 Mn |
| Jun 30, 2024 | 15.17 Mn |
| Jun 30, 2024 | 15.17 Mn |
| Dec 31, 2023 | 27.26 Mn |
| Dec 31, 2023 | 27.26 Mn |
| Sep 30, 2023 | 20.22 Mn |
| Sep 30, 2023 | 20.22 Mn |
| Jun 30, 2023 | 13.29 Mn |
| Jun 30, 2023 | 13.29 Mn |
| Dec 31, 2022 | 24.32 Mn |
| Dec 31, 2022 | 24.32 Mn |
| Dec 31, 2021 | 16.41 Mn |
| Dec 31, 2021 | 16.41 Mn |
| Dec 31, 2020 | 12.89 Mn |
| Dec 31, 2020 | 12.89 Mn |
| Dec 31, 2019 | 8.10 Mn |
| Dec 31, 2019 | 8.10 Mn |
| Dec 31, 2018 | 6.17 Mn |
| Dec 31, 2018 | 6.17 Mn |
| Dec 31, 2017 | 3.78 Mn |
| Dec 31, 2017 | 3.78 Mn |
| Mar 31, 2017 | 654,000.00 |
| Mar 31, 2017 | 654,000.00 |
| Dec 31, 2016 | 2.30 Mn |
| Dec 31, 2016 | 2.30 Mn |
| Sep 30, 2016 | 1.81 Mn |
| Sep 30, 2016 | 1.81 Mn |
| Jun 30, 2016 | 600,000.00 |
| Jun 30, 2016 | 600,000.00 |
| Mar 31, 2016 | 500,000.00 |
| Mar 31, 2016 | 500,000.00 |
| Dec 31, 2015 | 1.75 Mn |
| Dec 31, 2015 | 1.75 Mn |
| Sep 30, 2015 | 1.20 Mn |
| Sep 30, 2015 | 1.20 Mn |
| Jun 30, 2015 | 745,000.00 |
| Jun 30, 2015 | 745,000.00 |
| Mar 31, 2015 | 338,000.00 |
| Mar 31, 2015 | 338,000.00 |
| Dec 31, 2014 | 800,000.00 |
| Dec 31, 2014 | 800,000.00 |
| Sep 30, 2014 | 520,000.00 |
| Sep 30, 2014 | 520,000.00 |